Hal Mintz, the manager of Sabby Capital, believes StemCells Inc (NASDAQ:STEM) is a good investment and has opened a position for his fund.
Keep Reading →
July 17 - Hedge Funds, News
In a new filing with the Securities and Exchange Commission, James E. Flynn of Deerfield Management, has revealed a 6.05% stake in Aerie Pharmaceuticals Inc (NASDAQ:AERI).
Keep Reading →
July 7 - Hedge Funds, News
Perceptive Advisors, managed by Joseph Edelman, is bullish on Amicus Therapeutics Inc. (NASDAQ:FOLD). In a new filing with the U.S.
Keep Reading →
July 2 - Hedge Funds, News
According to our research, stocks bought by insiders demonstrate a small outperformance effect, which seems logical given the fact that insiders are the most knowledgeable about...
Keep Reading →
April 4 - Hedge Funds, Insider Trading, News
HSBC Hedge Weekly, in its issue Nr. 48, has published a list of the best hedge fund returns.
Keep Reading →
December 18 - Hedge Funds, News
Joseph Edelman's fund Perceptive Advisors continues its bullish streak on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) disclosing increasing its position to over 6.57 million shares...
Keep Reading →
November 12 - Hedge Funds, News
Joseph Edelman's fund, Perceptive Advisors, in a new filing reported increasing its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) again, after disclosing a buy of around...
Keep Reading →
November 6 - Hedge Funds, News
Hedge fund Perceptive Advisors, founded and managed by Joseph Edelman, increased its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) by some 360,700 shares, to a total ...
Keep Reading →
November 4 - Hedge Funds, News
In the 21st century investor’s toolkit, there are dozens of indicators shareholders can use to analyze publicly traded companies.
Keep Reading →
September 17 - News
Now, according to many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten age.
Keep Reading →
September 6 - News
To the average investor, there are dozens of methods investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading sentiment.
Keep Reading →
September 4 - News
In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.
Keep Reading →
September 4 - News
In the financial world, there are a multitude of gauges investors can use to watch publicly traded companies. A couple of the best are hedge fund and insider trading interest.
Keep Reading →
August 30 - News
If you were to ask many of your fellow readers, hedge funds are seen as overrated, old investment vehicles of a period lost to current times.
Keep Reading →
August 30 - News
In today’s marketplace, there are tons of gauges market participants can use to track their holdings.
Keep Reading →
August 28 - News
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies.
Keep Reading →
August 26 - News
If you were to ask many of your peers, hedge funds are assumed to be overrated, outdated financial vehicles of a forgotten age.
Keep Reading →
August 22 - News
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.
Keep Reading →
August 6 - News
To most shareholders, hedge funds are perceived as slow, outdated investment vehicles of yesteryear.
Keep Reading →
June 27 - News
Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) a first-rate investment today? Hedge funds are getting less optimistic.
Keep Reading →
June 26 - News
Pacific Biosciences of California (NASDAQ:PACB) was in 7 hedge funds' portfolio at the end of the first quarter of 2013.
Keep Reading →
June 19 - News
In today’s marketplace, there are plenty of indicators market participants can use to track publicly traded companies.
Keep Reading →
June 17 - News
At the moment, there are tons of metrics shareholders can use to watch Mr. Market. A pair of the most underrated are hedge fund and insider trading movement.
Keep Reading →
June 10 - News
Keryx Biopharmaceuticals (NASDAQ:KERX) was in 6 hedge funds' portfolio at the end of December.
Keep Reading →
April 18 - News
In the 21st century investor’s toolkit, there are dozens of metrics investors can use to watch stocks.
Keep Reading →
April 18 - News
In the financial world, there are a multitude of methods market participants can use to monitor publicly traded companies.
Keep Reading →
April 10 - News
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) was in 9 hedge funds' portfolio at the end of the fourth quarter of 2012.
Keep Reading →
April 10 - News
To most stock holders, hedge funds are seen as unimportant, outdated financial vehicles of yesteryear.
Keep Reading →
April 4 - News
Is EXACT Sciences Corporation (NASDAQ:EXAS) ready to raly soon? Investors who are in the know are becoming less hopeful.
Keep Reading →
April 4 - News
Is athenahealth, Inc (NASDAQ:ATHN) an outstanding investment now? Prominent investors are selling.
Keep Reading →
April 3 - News
Is Cynosure, Inc. (NASDAQ:CYNO) the right pick for your portfolio? Prominent investors are in a bullish mood.
Keep Reading →
April 2 - News
Is Dyax Corp. (NASDAQ:DYAX) the right investment to pursue these days? The best stock pickers are taking a bullish view.
Keep Reading →
April 1 - News
To the average investor, there are a multitude of indicators shareholders can use to watch the equity markets.
Keep Reading →
March 31 - News
Capital Senior Living Corporation (NYSE:CSU) was in 12 hedge funds' portfolio at the end of December.
Keep Reading →
March 29 - Hedge Funds
At the moment, there are tons of metrics market participants can use to watch their holdings. A pair of the most underrated are hedge fund and insider trading movement.
Keep Reading →
March 27 - News
Baker Brothers, a healthcare focused hedge fund managed by Julian and Felix Baker, has recently filed with the SEC to disclose significant percentage stakes in two development...
Keep Reading →
February 4 - Hedge Funds
David Tepper, the hedge-fund manager who runs the $15 billion Appaloosa Management LP, said he’s bullish on U.S.
Keep Reading →
January 23 - Hedge Funds
The most up-to-date publicly available information on hedge funds comes from 13D and 13G filings, which take place shortly after a fund or other institutional investor owns over...
Keep Reading →
January 16 - Hedge Funds
Since the end of 2Q, the very popular biopharma companies, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) and Vivus, Inc.
Keep Reading →
October 11 - Hedge Funds
